Location of Repository

The spectrum of p53 mutations in colorectal adenomas differs from that in colorectal carcinomas

By Xingpei Hao, Ian M. Frayling, J.G. Sgouros, M.Q. Du, Teresa Willocks, Ian C. Talbot and Ian P.M. Tomlinson

Abstract

Background: p53 mutations are frequently observed in colorectal carcinomas but they have also been found in colorectal adenomas, although considerably less frequently.\ud Aims: To explore p53 mutations in benign tumours, we have screened 70 colorectal adenomas for allelic loss at, and point mutations in, TP53 by analysis of selected microdissected cell populations.\ud Results: Sixteen (22.8%) adenomas were found to have allelic loss, of which 11 (15.7%) had p53 mutations. In adenomas with mild, moderate, or severe dysplasia, mutation or allelic loss occurred in 4.8%, 16.7%, and 52.6%, respectively (p<0.001). Seven different mutations were found, all missense changes or inframe deletions: one (Thr150Arg) has not been found before while three (Gln144His, Gly245Arg, and Glu285Gln) have not been described previously in colorectal tumours. The other\ud three mutations (Arg175Gly, Delta Pro190, and Gly245Ser) have been found in colorectal carcinomas, the last commonly. Adenomas harboured a spectrum of p53 mutations which was significantly different from cancers as regards the position in the gene and a higher frequency of G-C/C-G changes.\ud Conclusions: Combining our data on adenomas with data already published and in comparison with the spectrum of mutations in colorectal carcinomas, it is suggested that some p53 mutations have a weaker effect than others and are therefore more likely to be found in adenomas which have not progressed to carcinomas

Topics: UOW2
OAI identifier: oai:westminsterresearch.wmin.ac.uk:349
Provided by: WestminsterResearch

Suggested articles

Preview

Citations

  1. (1993). A first-generation physical map of the human genome.
  2. (1994). A frequent alteration of p53 gene in carcinoma in adenoma of colon.
  3. (1990). A genetic model for colorectal tumorigenesis. Cell
  4. (1997). Allele loss in colorectal cancer at the Cowden disease/juvenile polyposis locus on 10q. Cancer Genet Cytogenet
  5. bcl-2 and p53 oncoprotein expression during colorectal tumorigenesis.
  6. Comparison of p53 gene mutation and protein overexpression in colorectal carcinomas.
  7. (1992). Detection of loss of heterozygosity at the human TP53 locus using a dinucleotide repeat polymorphism. Genes Chromosomes Cancer
  8. (1999). Evolutionary conservation and somatic mutation hotspot maps of p53: correlation with p53 protein structural and functional features. Oncogene
  9. (1992). Genetic changes of both p53 alleles associated with the conversion from colorectal adenoma to early carcinoma in familial adenomatous polyposis and non-familial adenomatous polyposis patients. Cancer Res
  10. Genetic events in sporadic colorectal adenomas: K-ras and p53 heterozygous mutations are not sufficient for malignant progression.
  11. IARC Database of p53 gene mutations in human tumors and cell lines: updated compilation, revised formats and new visualisation tools.
  12. (1997). K-ras and p53 mutations in hereditary non-polyposis colorectal cancers.
  13. (1995). Microallelotyping defines the sequence and tempo of allelic losses at tumour suppressor gene loci during colorectal cancer progression. Nat Med
  14. (1994). Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res
  15. Northwick Park Hospital) for the generous loan of a Genephor
  16. Over-expression of p53 nuclear oncoprotein in colorectal adenomas.
  17. (1998). p53 gene mutation: software and database.
  18. (1992). P53 in tumour pathology: can we trust immunocytochemistry?
  19. (1991). p53 mutations in human cancers.
  20. (1996). p53 tumor suppressor gene: from the basic research laboratory to the clinic—an abridged historical perspective. Carcinogenesis
  21. p53, the cellular gatekeeper for growth and division.
  22. Polymerase chain reaction-based approaches for detection of allelic loss in the p53 tumor suppressor gene in colon neoplasms.
  23. (2001). TP53 mutations in breast cancer associated with BRCA1 or BRCA2 germ-line mutations: distinctive spectrum and structural distribution. Cancer Res
  24. (1993). Walter Hubert Lecture: the role of the p53 tumour-suppressor gene in tumorigenesis.

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.